¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"subendocardial myocardial infarction"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • pulmonary infarction
    Æó°æ»öÁõ, ÇãÆÄ°æ»öÁõ
  • segmental infarction
    ±¸¿ª°æ»ö
  • watershed infarction
    ºÐ¼ö°è°æ»öÁõ
  • idiopathic myocardial hypertrophy
    Ư¹ß½É±Ùºñ´ë, ¿øÀκҸí½É±Ùºñ´ë
  • myocardial
    ½ÉÀå±ÙÀ°-, ½É±Ù-
  • myocardial anoxia
    ½É±Ù¹«»ê¼ÒÁõ, ½ÉÀå±ÙÀ°¹«»ê¼ÒÁõ
  • myocardial bridging
    ½É±Ù´Ù¸®
  • myocardial contractility
    ½É(Àå)±Ù(À°)¼öÃà·Â, ½É(Àå)±Ù(À°)¼öÃ༺
  • myocardial contraction
    ½É(Àå)±Ù(À°)¼öÃà
  • myocardial depressant factor
    ½É(Àå)±Ù(À°)¾ïÁ¦ÀÎÀÚ
  • myocardial failure
    ½É±Ù±â´É»ó½Ç, ½É±ÙºÎÀü
  • myocardial irritability
    ½É±Ù°ú¹Î¼º, ½É±ÙÀÚ±ØÈïºÐ¼º
  • myocardial ischemia
    ½É±ÙÇãÇ÷, ½ÉÀå±ÙÀ°ÇãÇ÷
  • myocardial lead
    ½É±ÙÀ¯µµ, ½ÉÀå±ÙÀ°À¯µµ
  • myocardial perfusion scintigraphy
    ½É±Ù°ü·ù¼¶±¤Á¶¿µ(¼ú)
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • pulmonary infarction
    Æó°æ»öÁõ, ÇãÆÄ°æ»öÁõ
  • segmental infarction
    ±¸¿ª°æ»ö
  • watershed infarction
    ³úºÐ¼ö°è°æ»ö
  • post-infarction syndrome
    °æ»öÈÄÁõÈıº
  • myocardial anoxia
    ½ÉÀå±ÙÀ°¹«»ê¼ÒÁõ
  • myocardial bridging
    ½É±Ù´Ù¸®
  • myocardial contractility
    ½ÉÀå±ÙÀ°¼öÃà·Â, ½ÉÀå±ÙÀ°¼öÃ༺
  • myocardial contraction
    ½ÉÀå±ÙÀ°¼öÃà
  • myocardial failure
    ½É±Ù±â´É»ó½Ç, ½É±ÙºÎÀü
  • myocardial depressant factor
    ½ÉÀå±Ù¾ïÁ¦ÀÎÀÚ
  • idiopathic myocardial hypertrophy
    Ư¹ß½É±Ùºñ´ë, ¿øÀκҸí½É±Ùºñ´ë
  • myocardial irritability
    ½É±Ù°ú¹Î¼º, ½É±ÙÀÚ±ØÈïºÐ¼º
  • myocardial ischemia
    ½É±ÙÇãÇ÷
  • myocardial lead
    ½É±ÙÀ¯µµ
  • myocardial
    ½ÉÀå±ÙÀ°-, ½É±Ù-
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • placental infarction
    Źݰæ»ö(÷ÃÚïÌÛßá)
  • post-infarction syndrome
    »öÀüÈÄ ÁõÈıº
  • postmyocardial infarction syndrome
    ½É±Ù°æ»öÈÄÁõÈıº.
  • postmyocardial infarction syndrome
    ½É±Ù°æ»öÈÄÁõÈıº(ãýÐÉÌÛßáý­ñøý¦ÏØ)
  • pulmonary infarction
    Æó°æ»ö
  • pulmonary infarction
    Æó°æ»öÁõ(øËÌÛßáñø)
  • renal infarction
    ½Å°æ»öÁõ(ãìÌÛßáñø).
  • renal infarction
    ½Å°æ»öÁõ(ãìÌÛßáñø)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • myocardial infarction,wavy fibers
    ÆÄµ¿Çü ¼¶À¯(÷îÔÑúþ àéë«)
  • old myocardial infarction
    Áø±¸¼º ½É±Ù°æ»ö(Áõ)(òçÏÁàõãýÐÉÌãßáñø),°ú°Å½É±Ù°æ»ö.
  • old myocardial infarction
    Áø±¸¼º ½É±Ù°æ»ö(Áõ)(òçÏÁàõãýÐÉÌãßáñø).
  • posterior (myocardial) infarction
    (½ÉÀå)Èĺ®°æ»öÁõ(ãýíôý­ÛúÌÛßáñø).
  • posterior (myocardial) infarction
    (½ÉÀå)Èĺ®°æ»öÁõ((ãýíô)ý­ÛúÌÛßáñø)
  • q wave,in myocardial infarction
    ½É±Ù°æ»öÀÇ (QÆÄ)(ãýÐÉÌÛßá¡­)
  • septal myocardial infarction
    Á߰ݽɱٰæ»öÁõ(ñḛ́ãýÐÉÌÛßáñø).
  • septal myocardial infarction
    Á߰ݽɱٰæ»öÁõ(ñḛ́ãýÐÉÌÛßáñø)
  • silent myocardial infarction
    ¹«Áõ»ó½É±Ù °æ»öÁõ.
  • silent myocardial infarction
    ¹«Áõ»ó½É±Ù°æ»öÁõ(¡­ãýÐÉÌÛßáñø)
  • subendocardial
    ½É³»¸·ÇÏ(ãýҮدù»)ÀÇ.
  • subendocardial branches
    ½ÉÀå¼Ó¸·¹Ø°¡Áö
  • subendocardial ischemia
    ½É³»¸·ÇÏÇãÇ÷(¡­úÈúì).
  • subendocardial ischemia
    ½É³»¸·ÇÏÇãÇ÷(¡­úÈúì)
  • anterolateral infarction
    Àüº®¿ÜÃø°æ»öÁõ(îñÛúèâö°ÌÛßáñø).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
TIMI trhombolysis in myocardial infarction; transmural inferior myocardial infarction
TMI testing motor impairment; threatened myocardial infarction; transmural myocardial infarction
AMI acquired monosaccharide intolerance; acute myocardial infarction; amitriptyline; anterior myocardial...
MI first meiotic metaphase; maturation index; medical illustrator; medical informatics; medical inspect...
SMI Self-Motivation Inventory; senior medical investigator; severe mental impairment; silent myocardial ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
TIMI Thombolysis in Myocardial Infarction
TIMI Thrombolysis In Myocardial Infarction trial
TAMI Thrombolysis and Angioplasty in Myocardial Infarction
AIMI acute inferior myocardial infarction
IMI inferior myocardial infarction
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • myocardial contractility
    ½É±Ù ¼öÃà·Â
  • myocardial contusion
    ½É±Ù Á»ó
  • myocardial degeneration
    ½É±Ù º¯¼º
  • myocardial depressant factor
    ½É±Ù ¾ïÁ¦ ÀÎÀÚ
  • myocardial failure
    ½É±Ù ºÎÀü
  • myocardial function
    ½É±Ù ±â´É
  • myocardial irritability
    ½É±Ù °ú¹Î¼º, ½É±Ù ÀÚ±Ø ÈïºÐ¼º
  • myocardial lead
    ½É±Ù À¯µµ
  • myocardial necrosis
    ½É±Ù ±«»ç
  • myocardial primordium
    ½ÉÀå ±ÙÀ°Ãþ ¿ø±â
  • myocardial scan
    ½É±Ù ÁÖ»ç
  • myocardial stimulants
    ½É±Ù ÀÚ±ØÁ¦
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
subendocardial <anatomy> Situated under the endocardium.
Source: Websters Dictionary
(01 Mar 1998)
subendocardial layer The loose connective tissue layer that joins the endocardium and myocardium; in the ventricles, it contains branches of the conducting system of the heart.
(05 Mar 2000)
cardiac infarction A term used to describe irreversible injury to heart muscle.
Synonym: heart attack.
See: infarction.
Common symptoms include substernal, crushing chest pain that may radiate to the jaw or arms. Chest pains may be associated with nausea, sweating and shortness of breath.
Acronym: MI
(27 Sep 1997)
cerebral infarction Infarction of brain tissue.
(12 Dec 1998)
peri-infarction block An electrocardiographic abnormality associated with an old myocardial infarct and caused by delayed activation of the myocardium in the region of the infarct; characterised by an initial vector directed away from the infarcted region with the terminal vector directed toward it.
(05 Mar 2000)
watershed infarction Cortical infarction in an area where the distribution of major cerebral arteries meet or overlap.
(05 Mar 2000)
postmyocardial infarction pericarditis <pathology> Inflammation of the pericardium.
(18 Nov 1997)
postmyocardial infarction syndrome <syndrome> A complication developing several days to several weeks after myocardial infarction; its clinical features are fever, leukocytosis, chest pain, and evidence of pericarditis, sometimes with pleurisy and pneumonitis, with a strong tendency to recurrence; probably of immunopathogenetic origin.
(05 Mar 2000)
heart rupture, post-infarction Rupture of the heart after myocardial infarction.
(12 Dec 1998)
splenic infarction Cell death (necrosis) of a portion or all of the spleen due to an interruption in blood flow.
(27 Sep 1997)
infarction 1. <cardiology> The formation of an infarct.
2. An infarct.
Origin: L. Infarcire = to stuff in
(18 Nov 1997)
biopsy, myocardial <investigation, procedure, surgery> A procedure which involves the removal of a small specimen of cardiac muscle tissue for microscopic analysis.
This is generally performed at the same time as a cardiac catheterisation or as a very similar, yet separate, procedure. A small piece of heart tissue is taken via a small forceps inserted into the cardiac catheter site (usually threaded through a vein in the neck).
This test may reveal the cause of a cardiomyopathy, myocarditis, amyloidosis or a heart transplant rejection.
(21 Mar 1998)
myocardial Refers to the heart's muscle mass.
(09 Oct 1997)
myocardial biopsy <procedure> A procedure which involves the removal of a small specimen of cardiac muscle tissue for microscopic analysis.
This is generally performed at the same time as a cardiac catheterisation or as a very similar, yet separate, procedure. A small piece of heart tissue is taken via a small forceps inserted into the cardiac catheter site (usually threaded through a vein in the neck). This test may reveal the cause of a cardiomyopathy, myocarditis, amyloidosis or a heart transplant rejection.
(27 Sep 1997)
myocardial bridge A bridge of cardiac muscle fibres extending over the epicardial aspect of a coronary artery; this finding, in cases of sudden unexpected death, has led to speculation that cardiac contraction during exertion could constrict the coronary artery.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á